Results 31 to 40 of about 3,661 (213)

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy [PDF]

International Journal of Women's Health, 2009
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, S Kellogg, M Krychman
doaj   +3 more sources

Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. [PDF]

J Clin Med, 2023
Lubián-López DM, Butrón-Hinojo CA, Menjón-Beltrán S, González-Mesa E, Tapiador-Albertos S, Rodríguez-Jiménez B, Fiol-Ruiz G.   +6 more
europepmc   +3 more sources

Non-hormonal therapies for vulvovaginal atrophy: Clinical cases

Гинекология
Menopause is associated with a deficiency of sex hormones, which significantly impacts a woman's physical and psycho-emotional state. In particular, the blood supply to the genitourinary system organs deteriorates, and the synthesis of connective tissue ...
Tatiana B. Motovilova, Liya Z. Sirotina, Oksana I. Trifonova, Irina A. Kruglova, Anastasiya D. Varnavskaya, Kseniia V. Kazakova   +5 more
doaj   +2 more sources

Fractional CO₂ laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women. [PDF]

Int J Womens Health, 2017
Arroyo C.
europepmc   +3 more sources

Vulvovaginal Atrophy [PDF]

Mayo Clinic Proceedings, 2010
Vulvovaginal atrophy (VVA) is a common and underreported condition associated with decreased estrogenization of the vaginal tissue. Symptoms include dryness, irritation, soreness, and dyspareunia with urinary frequency, urgency, and urge incontinence. It can occur at any time in a woman's life cycle, although more commonly in the postmenopausal phase ...
Maire B, Mac Bride, Deborah J, Rhodes, Lynne T, Shuster   +2 more
openaire   +4 more sources

Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. [PDF]

Breast Cancer Res Treat
Faltinová M, Vehmanen L, Lyytinen H, Savolainen-Peltonen H, Virtanen A, Haanpää M, Hämäläinen E, Tiitinen A, Mattson J.   +8 more
europepmc   +3 more sources

Vulvovaginal atrophy in postmenopausal women: diagnosis and modern-day treatments

Лечащий Врач, 2022
The article is devoted to the study of modern methods of diagnosis and treatment of benign diseases of the vulva and vagina in postmenopausal women.
K. R. Bahtiyarov, R. A. Chilova, Sh. Sh. Sardarova   +2 more
doaj   +1 more source

Vulvovaginal atrophy: issues of treatment and rehabilitation: A review [PDF]

Гинекология, 2022
The review presents data on the management tactics of women with vulvovaginal atrophy in patients of reproductive age and menopause. The influence of vulvovaginal atrophy on the psycho-emotional and sexual spheres, modern methods of diagnosis and therapy
Diana M. Ampilogova, Antonina G. Solopova, Dmitry V. Blinov, Evgeny E. Achkasov, Daria A. Petrenko, Daniil I. Korabelnikov   +5 more
doaj   +1 more source

The Role of Topical Treatment on Vaginal Tightening

Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2022
Background: Physiological changes in a woman's life, such as labor, weight fluctuations, hormonal changes, aging, and menopause, cause changes in both appearance and function of the vagina.
Made Putri Hendaria
doaj   +1 more source

Understanding the Benefits of CO₂ Laser Treatment for Vulvovaginal Atrophy. [PDF]

Medicina (Kaunas)
Jankovic S, Rovcanin M, Tomic A, Jurisic A, Milovanovic Z, Zamurovic M.   +5 more
europepmc   +3 more sources